Catecholamines affect the binding of opioids to δ and K receptors in rat heart sarcolemmal membranes

Catecholamines affect the binding of opioids to δ and K receptors in rat heart sarcolemmal membranes

J Mol Cell Cardiol21 (Supplement II) (1989) 538 STIMULATORY EFFECT OF CATALYTIC SUBUNIT OF CYCLIC AMP-DEPENDENT PROTEIN KINASE ON LIPID METHYLAT...

102KB Sizes 2 Downloads 76 Views

J Mol

Cell

Cardiol21

(Supplement

II) (1989)

538

STIMULATORY EFFECT OF CATALYTIC SUBUNIT OF CYCLIC AMP-DEPENDENT PROTEIN KINASE ON LIPID METHYLATION IN ISOLATED CARDIAC SARCOLEMMA. R. Vetter, :‘. Panagia, J. Dai, Y. Taira, N.S. Dhalla. Division of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, and Departments of Physiology and Anatomy, Faculty of Medicine, University of Manitoba, Winnipeg, Canada. Purified sarcolemmal (SL) membranes, from both rat and pig myocardium exhibit increased methyltransferase activity after preincubation with MgATP and catalytic subunit of cyclic AMP-dependent protein kinase. Prephosphorylation of membranes stimulates c3Hl-methyl incorporation into SL lipids assayed at 0.15 uM S-adenosyl-L-[methyl-3H1 methionine ([3H]-AdoMet) 2.4- and 1.4- fold in rat and pig heart membrane preparations, respectively. Kinetic analysis of the methylation reaction reveals that the stimulation is due to an enhancement of Vmax. The Km of the high-affinity methylation reaction, ranging from 0.08 to 0.11 uM, is not changed under phosphorylating conditions. Premethylation of SL in the presence of 0.15 to 150 uM AdoMet did not change the phosphorylation of SL substrates catalyzed either by endogenous cyclic AMP-dependent protein kinase or by added catalytic This study suggests that cardiac SL methyltransferase@, which is (are) involved subunit. in the covalent modification of membrane lipids, can be controlled by cyclic AMP-dependent protein phosphorylation. It indicates also that the lipid composition of the sarcolemma may be under beta-adrenergic control. (Supported by a grant from the Medical Research Council of Canada).

5%

EFFECTS A. Pentz, Stellenbosch of South

OF METABOLIC I.S. Harper. Medical Africa.

MANIPULATION MRC Centre School; MRC

ON MYOCARDIAL for Molecular Institute for

SARCOLEMMAL PERMEABILITY. A. and Cellular Biology, University Medical Biophysics, Tygerberg,

Lochner, of Republic

The harmful effects of free fatty acids and the protection afforded by glucose on the ischaemic heart are well documented. However, the mechanisms involved in these pro= cesses are poorly understood. To determine whether metabolic manipulation of the sub= thereby impairing intracel= strate supply act through altered sarcolemmal permeability, lular ionic homeostasis, isolated rat hearts were subjected to control and hypoxic low-flow perfusion using glucose, palmitate or glucose plus palmitate as substrates. Sarcolemmal permeability was quantified using an ultrastructural probe (ionic lantha= num) as well as LDH release. Palmitate (0.5 mM, palmitate/albumin molar ratio 5) as well as substrate-free perfusion increased lanthanum influx, LDH release and intracel= lular Ca2+ levels in hypoxic, low-flow perfused hearts. Glucose (10 mM) as substrate afforded significant protection against ischaemic damage as evidenced by a reduction of al I three above-mentioned parameters. In summary, palmitate as substrate can cause . . ;;.e;re sarcolemmal Injury, whereas glucose reduces membrane impairment and cellular overloadrng. These substrate effects were associated with marked changes in sar= colemmal phospholipid-fatty acid composition, which could be the cause of the increased membrane permeab i I i ty .

540

CATECHOLAMINES

AFFECT

THE

BINDING

C.

Ventura,

L.

Bastagli,

P.

of

Research

on

Cardiac

Metabolism,

Thj using

apioid

[

gene

284.3

and,

to

the

prot the

agonist

value

This

effect

in

KD

value.

phentolamine

ly

inhibited

+

stimulated

was

associated

(1

by

DADLE of

opioid

catecholamine

and,

sarcolemmal

a radioligand.

nM

prot)

displaced

with

produced

to

a

receptors

interaction

lower

6

of with

a

Emax

and

extent,

by

and

K

and

R

MEMBRANES.

Biochemistry,

Centre

2

paralleled

the

KD

and

R-agonists

30

type sarcolemmal

and

Bmax as

by

was

the

vajue [

results

indicate

that

adrenoceptors.

and

values DADLE

HI-DPN

phenyl-

an

increase

2

0.1

higher without

completely

opioidergic

whilst

a-agonist

(1.3

demonstrate this

K

agoni:t

6

prat) was

by of

manner,

opioid These

the

by

fmol/mg

R-adrenergic-stimulated U50.48BH.

S.180

a-

basal

of

(610.5

ventricles concentrations

dose-dependent

concentrations

value the

in

at

well

stimulated effect

decrease at

The

a

heart

found

as

in

H]-DPN

an

rat

was

DPN,

markedly

a

both

D-

[

Such

only

the

by The

respectively.

SARCOLEMMAL of

binding.

was

-DPN.

binding

in

increase

action

H]

HEART

from

binding

bound

with

the

an

isolated

cooperative

binding

[

RAT

Department

Unljbeled

together

increased

PM)

a

Thq

IN

Saturable

respectively.

nM

RECEPTORS

Guarnieri.

membranes

suggested 0.3

K C.

Italy.

in

0.5-20

fmol/ng

AND and

as

ineffective. of

6

Bologna,

lJ50,4BBH,

was

propranolol

of

+

agonist

stimulatory and

by

K

38

TO Caldarera

analysis 4.2

presence

(988.4

The

sarcolemma,

HI-DPN)

and

DAGO

the

isoproterenal

by

[

Scatchard

The

fmol/mg extent

vM)

Bmax

D-agonist

the

H]-DPN. 20

lower

(1

gerfarmed

(

p selective

the

the

+ a

ephrine

nM.

[

nM

OPIOIDS C.M.

University

was

H]-Digrenorphine

20

about

binding

OF

Bernardi,

in

nM).

The

than

2.5

altering antagonized

binding

was the

partial-

in

presence, system

nay

be